(lp0
S"Incyte Corporation at the Cowen Healthcare Conference: 4 Things You'll Want to ... Motley Fool - Mar 9, 2017 Few biotechs have enjoyed as fun a ride as Incyte Corporation  in recent years. The stock has soared more than 700% since early 2012 thanks primarily to tremendous success for cancer drug Jakafi.Earnings Clues on Incyte Corporation , Mastercard Incorporated (MA ... - StockNewsJournal"
p1
aS"Incyte Corporation Stock Rises on Price Target Increase TheStreet.com - Mar 13, 2017 Incyte  shares were up 1.3% to $151.21 in premarket trading Monday after analysts at Credit Suisse raised the company's price target to $174 from $136.Gilead Looking To Buy Incyte? It Makes Sense - BenzingaWhy Investors remained confident on Realty Income Corporation , Incyte ... - StockNewsJournal"
p2
aS"Why Incyte Corporation  Shares Are Skyrocketing Simply Wall St - Mar 12, 2017 Including an 8% jump on Friday, Incyte Corporation  shares are up a staggering 110% over the past year. The Delaware-based biotech firm is experiencing a growing demand for its cancer drug Jakafi (to treat myelofibrosis and polycythemia&nbsp;...Incyte Corporation  Moves Higher on Volume Spike for March 10 - Equities.comReliable stocks in today's share market: Incyte Corporation  - The News Journal"
p3
aS'Penn cancer center forms research partnership with Incyte pharmaceutical company The Daily Pennsylvanian - Mar 2, 2017 Incyte Corporation, a pharmaceutical company, is entering into a multi-year research partnership with the Abramson Cancer Center at Penn.'
p4
aS'Incyte Corporation Risk Points versus Health Care CML News - 10 hours ago This is a scatter plot analysis of the critical risk points from the option market for Incyte Corporation  compared to its own past and the Health Care ETF.'
p5
aS"Analyst's Predictions on Incyte Corporation , Devon Energy Corporation  StockNewsJournal - Mar 13, 2017 Incyte Corporation  have shown a high EPS growth of 18.70% in the last 5 years and has earnings decline of -25.90% yoy.Hot Stocks to Track: Incyte Corporation , Devon Energy ... - TRAInvestment Research Analysts Opinion: Incyte Corporation , Devon Energy ... - TWN"
p6
aS"Incyte: Many Strengths, Small EPS, So What's It Worth? Seeking Alpha - Feb 17, 2017 Incyte  has now reported its Q4 and full-year financial results, and provided an update on its business. Since there were not a lot of surprises therein, I'll get to them later, but as I've previously said in a Dec. 5 article titled Incyte ...Incyte Corporation  Earns Buy Rating from JP Morgan Chase &amp; Co - BNB Daily "
p7
aS'Incyte Corporation Bottom Line Falls 84% In Q4 Nasdaq - Feb 14, 2017  - Incyte Corporation  revealed earnings for fourth quarter that declined from last year. The company said its earnings came in at $8.87 million, or $0.05 per share.'
p8
aS'Incyte Corporation: Incyte Announces Oncology Research Alliance with the ... The Wall Street Transcript - Feb 23, 2017 BUSINESS WIRE)--Feb. 23, 2017-- Incyte Corporation  today announces a multi-year research collaboration with the Abramson Cancer Center at the University of Pennsylvania.University of Pennsylvania announces cancer research alliance with Incyte - DOTmed.com'
p9
aS'How Incyte Stock Became a Bull Market Star for Biotech Investors Yahoo Finance - Mar 10, 2017 While several stocks performed well during this period, Incyte Corporation INCY tops the list -- this bull market outperformer gained a whopping 5797.9% during this 8-year period, outperforming the Zacks-categorized Medical-Biomedical/Genetics industry ...'
p10
a.